Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 32


Osteoprotegerin rich tumor microenvironment: implications in breast cancer.

Goswami S, Sharma-Walia N.

Oncotarget. 2016 Apr 8. doi: 10.18632/oncotarget.8658. [Epub ahead of print] Review.


Implications of a peroxisome proliferator-activated receptor alpha (PPARĪ±) ligand clofibrate in breast cancer.

Chandran K, Goswami S, Sharma-Walia N.

Oncotarget. 2016 Mar 29;7(13):15577-99. doi: 10.18632/oncotarget.6402.


Lipoxins: nature's way to resolve inflammation.

Chandrasekharan JA, Sharma-Walia N.

J Inflamm Res. 2015 Sep 30;8:181-92. doi: 10.2147/JIR.S90380. eCollection 2015. Review.


Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi's sarcoma cells.

Marginean A, Sharma-Walia N.

Transl Res. 2015 Aug;166(2):111-33. doi: 10.1016/j.trsl.2015.02.009. Epub 2015 Mar 6.


Glutamate secretion and metabotropic glutamate receptor 1 expression during Kaposi's sarcoma-associated herpesvirus infection promotes cell proliferation.

Valiya Veettil M, Dutta D, Bottero V, Bandyopadhyay C, Gjyshi O, Sharma-Walia N, Dutta S, Chandran B.

PLoS Pathog. 2014 Oct 9;10(10):e1004389. doi: 10.1371/journal.ppat.1004389. eCollection 2014 Oct.


The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis.

Sharma-Walia N, Chandran K, Patel K, Veettil MV, Marginean A.

J Virol. 2014 Feb;88(4):2131-56. doi: 10.1128/JVI.02786-13. Epub 2013 Dec 11. Erratum in: J Virol. 2014 May;88(9):5206.


Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.

Paul AG, Chandran B, Sharma-Walia N.

Transl Res. 2013 Aug;162(2):77-92. doi: 10.1016/j.trsl.2013.03.004. Epub 2013 Apr 6. Review.


Angiogenin functionally interacts with p53 and regulates p53-mediated apoptosis and cell survival.

Sadagopan S, Veettil MV, Chakraborty S, Sharma-Walia N, Paudel N, Bottero V, Chandran B.

Oncogene. 2012 Nov 15;31(46):4835-47. doi: 10.1038/onc.2011.648. Epub 2012 Jan 23.


COX-2/PGE2: molecular ambassadors of Kaposi's sarcoma-associated herpes virus oncoprotein-v-FLIP.

Sharma-Walia N, Patel K, Chandran K, Marginean A, Bottero V, Kerur N, Paul AG.

Oncogenesis. 2012 Apr 2;1:e5. doi: 10.1038/oncsis.2012.5.


Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphoma.

Paul AG, Sharma-Walia N, Chandran B.

PLoS One. 2011;6(9):e24379. doi: 10.1371/journal.pone.0024379. Epub 2011 Sep 30.


IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection.

Kerur N, Veettil MV, Sharma-Walia N, Bottero V, Sadagopan S, Otageri P, Chandran B.

Cell Host Microbe. 2011 May 19;9(5):363-75. doi: 10.1016/j.chom.2011.04.008.


Phosphorylation and polyubiquitination of transforming growth factor beta-activated kinase 1 are necessary for activation of NF-kappaB by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.

Bottero V, Kerur N, Sadagopan S, Patel K, Sharma-Walia N, Chandran B.

J Virol. 2011 Mar;85(5):1980-93. doi: 10.1128/JVI.01911-10. Epub 2010 Dec 15.


NFAT and CREB regulate Kaposi's sarcoma-associated herpesvirus-induced cyclooxygenase 2 (COX-2).

Sharma-Walia N, George Paul A, Patel K, Chandran K, Ahmad W, Chandran B.

J Virol. 2010 Dec;84(24):12733-53. doi: 10.1128/JVI.01065-10. Epub 2010 Oct 13.


Characterization of entry and infection of monocytic THP-1 cells by Kaposi's sarcoma associated herpesvirus (KSHV): role of heparan sulfate, DC-SIGN, integrins and signaling.

Kerur N, Veettil MV, Sharma-Walia N, Sadagopan S, Bottero V, Paul AG, Chandran B.

Virology. 2010 Oct 10;406(1):103-16. doi: 10.1016/j.virol.2010.07.012. Epub 2010 Aug 1.


Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen.

George Paul A, Sharma-Walia N, Kerur N, White C, Chandran B.

Cancer Res. 2010 May 1;70(9):3697-708. doi: 10.1158/0008-5472.CAN-09-3934. Epub 2010 Apr 13.


Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion.

Sharma-Walia N, Paul AG, Bottero V, Sadagopan S, Veettil MV, Kerur N, Chandran B.

PLoS Pathog. 2010 Feb 12;6(2):e1000777. doi: 10.1371/journal.ppat.1000777.


Kaposi sarcoma-associated herpes virus (KSHV) G protein-coupled receptor (vGPCR) activates the ORF50 lytic switch promoter: a potential positive feedback loop for sustained ORF50 gene expression.

Bottero V, Sharma-Walia N, Kerur N, Paul AG, Sadagopan S, Cannon M, Chandran B.

Virology. 2009 Sep 15;392(1):34-51. doi: 10.1016/j.virol.2009.07.002. Epub 2009 Jul 28.


Kaposi's sarcoma-associated herpesvirus utilizes an actin polymerization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells.

Raghu H, Sharma-Walia N, Veettil MV, Sadagopan S, Chandran B.

J Virol. 2009 May;83(10):4895-911. doi: 10.1128/JVI.02498-08. Epub 2009 Mar 11.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk